Personal genome analysis in amyotrophic lateral sclerosis

Brain and Nerve

Volumn 65, Issue 3, 2013, Pages 257-265

  Tanaka, Fumiaki ^a   Sone, Jun ^b   Atsuta, Naoki ^b   Nakamura, Ryoichi ^b   Doi, Hiroshi ^a   Koyano, Shigeru ^a   Sobue, Gen ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ALS; C9orf72; GWAS; Next generation sequencing; ZBF5I2B

Indexed keywords

ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMOSOME 9; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; MOLECULAR DIAGNOSIS; NUCLEOTIDE REPEAT; OPEN READING FRAME;

AMYOTROPHIC LATERAL SCLEROSIS; GENETIC LINKAGE; GENETIC PRIVACY; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTATION;

EID: 84875821201     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, et al: Amyotrophic lateral sclerosis. Lancet 377: 942-955, 2011
2. The Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971-983, 1993
3. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, et al: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50: 509-517, 1987
4. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, et al: Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323: 646-650, 1986
5. Collins FS: Positional cloning: let's not call it reverse anymore. Nat Genet 1: 3-6, 1992
6. Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, et al: The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 124: 339-352, 2012
7. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993
8. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al: Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772-1775, 1994
9. Morren JA, Galvez-Jimenez N: Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis. Expert Opin Investig Drugs 21: 297-320, 2012
10. Ikenaka K, Kawai K, Katsuno M, Huang Z, Jiang YM, et al: dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration. PLoS One (in press)
11. Iguchi Y, Katsuno M, Niwa J, Takagi S, Ishigaki S, et al: Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain (in press)
12. Tsuji S: Genetics of neurodegenerative diseases: insights from high-throughput resequencing. Hum Mol Genet 19: R65-R70, 2010
13. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, et al: A hexanucleotide repeat expansion in C90RF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268, 2011
14. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256, 2011
15. Majounie E, Renton AE, Mok K, Dopper EG, Waite A, et al: Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11: 323-330, 2012
16. Le Ber I, van der Zee J, Hannequin D, Gijselinck I, Campion D, et al: Progranulin null mutations in both sporadic and familial frontotemporal dementia. Hum Mutat 28: 846-855, 2007
17. Ogaki K, Li Y, Atsuta N, Tomiyama H, Funayama M, et al: Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 33: 2527 e2511-e2526, 2012
18. Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, et al: C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch Neurol 69: 1154-1158, 2012
19. Doi H, Yoshida K, Yasuda T, Fukuda M, Fukuda Y, et al: Exorne sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. Am J Hum Genet 89: 320-327, 2011
20. Laing NG: Genetics of neuromuscular disorders. Crit Rev Clin Lab Sci 49: 33-48, 2012
21. Hoischen A, Gilissen C, Arts P, Wieskamp N, van der Vliet W, et al: Massively parallel sequencing of ataxia genes after array-based enrichment. Hum Mutat 31: 494-499, 2010
22. Walsh T, Lee MK, Casadei S, Thornton AM, Stray SM, et al: Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A 107: 12629-12633, 2010
23. Simpson DA, Clark GR, Alexander S, Silvestri G, Willoughby CE: Molecular diagnosis for heterogeneous genetic diseases with targeted high-throughput DNA sequencing applied to retinitis pigmentosa. J Med Genet 48: 145-151, 2011
24. McCarthy MI, Hirschhorn JN: Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17: R156-R165, 2008
25. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al: A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861, 2007
26. Visscher PM, Brown MA, McCarthy MI, Yang J: Five years of GWAS discovery. Am J Hum Genet 90: 7-24, 2012
27. Schymick JC, Scholz SW, Fung HC, Britton A, Arepalli S, et al: Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 6: 322-328, 2007
28. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, et al: Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med 357: 775-788, 2007
29. van Es MA, Van Vught PW, Blauw HM, Franke L, Saris CG, et al: ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 6: 869-877, 2007
30. van Es MA, van Vught PW, Blauw HM, Franke L, Saris CG, et al: Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 40: 29-31, 2008
31. van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, et al: Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 41: 1083-1087, 2009
32. Laaksovirta H, Peuralinna T, Schymick JC, Scholz SW, Lai SL, et al: Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol 9: 978-985, 2010
33. Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, et al: Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol 9: 986-994, 2010
34. Cronin S, Tomik B, Bradley DG, Slowik A, Hardiman O: Screening for replication of genome-wide SNP associations in sporadic ALS. Eur J Hum Genet 17: 213-218, 2009
35. Fernandez-Santiago R, Sharma M, Berg D, Illig T, Anneser J, et al: No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort. Neurobiol Aging 32: 551 e551-e554, 2011
36. Iida A, Takahashi A, Kubo M, Saito S, Hosono N, et al: A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Hum Mol Genet 20: 3684-3692, 2011
37. Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, et al: Functional proteomics mapping of a human signaling pathway. Genome Res 14: 1324-1332, 2004
38. Atsuta N, Watanabe H, Ito M, Tanaka F, Tamakoshi A, et al: Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci 276: 163-169, 2009
39. Czaplinski A, Yen AA, Appel SH: Amyotrophic late-ral sclerosis: early predictors of prolonged survival. J Neurol 253: 1428-1436, 2006
40. Talbot K: Motor neuron disease: the bare essentials. Pract Neurol 9: 303-309, 2009
41. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G: Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60: 813-819, 2003
42. Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, et al: Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11: 232-240, 2012
43. Tetsuka S, Morita M, Iida A, Uehara R, Ikegawa S, et al: ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis. J Neurol Sci 324: 163-166, 2013
44. Chio A, Mora G, Restagno G, Brunetti M, Ossola I, et al: UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study. Neurobiol Aging 34: 357 e351-355, 2013
45. Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, et al: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466: 1069-1075, 2010
46. Chen Y, Huang R, Yang Y, Chen K, Song W, et al: Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging 32:1925 e1921-1925, 2011
47. Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, et al: ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130: 575-580, 2011
48. Daoud H, Belzil V, Martins S, Sabbagh M, Provencher P, et al: Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis. Arch Neurol 68: 739-742, 2011
49. Lee T, Li YR, Ingre C, Weber M, Grehl T, et al: Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet 20: 1697-1700, 2011
50. Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, et al: Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 20: 3207-3212, 2011
51. Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, et al: Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76: 2066-2072, 2011
52. Lahut S, Omur O, Uyan O, Agim ZS, Ozoguz A, et al: ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population. PLoS One 7: e42956, 2012
53. Raiser M, Nonhoff U, Albrecht M, Lengauer T, Wanker EE, et al: Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Hum Mol Genet 14: 2893-2909, 2005
54. Nonis D, Schmidt MH, van de Loo S, Eich F, Dikic I, et al: Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal 20: 1725-1739, 2008
55. Gispert S, Kurz A, Waibel S, Bauer P, Liepelt I, et al: The modulation of amyotrophic lateral sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 45: 356-361, 2012
56. Lee T, Li YR, Chesi A, Hart MP, Ramos D, et al: Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology 76: 2062-2065, 2011
57. Lastres-Becker I, Rub U, Auburger G: Spinocerebellar ataxia 2 (SCA2). Cerebellum 7: 115-124, 2008
58. Corrado L, Mazzini L, Oggioni GD, Luciano B, Godi M, et al: ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130: 575-580, 2011
59. Sobczak K, Krzyzosiak WJ: CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J Biol Chem 280: 3898-3910, 2005
60. Ralser M, Nonhoff U, Albrecht M, Lengauer T, Wanker EE, et al: Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Hum Mol Genet 14: 2893-2909, 2005
61. Satterfield TF, Pallanck LJ: Ataxin-2 and its Drosophila homolog, ATX2, physically assemble with polyribosomes. Hum Mol Genet 15: 2523-2532, 2006
62. Nonhoff U, Raiser M, Welzel F, Piccini I, Balzereit D, et al: Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell 18: 1385-1396, 2007
63. Nonis D, Schmidt MH, van de Loo S, Eich F, Dikic I, et al: Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell Signal 20: 1725-1739, 2008
64. Nanetti L, Fancellu R, Tomasello C, Gellera C, Pareyson D, et al: Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J Neurol 256: 1926-1928, 2009
65. Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, et al: Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 19: 622-629, 2004
66. Gwinn-Hardy KA, Crook R, Lincoln S, Adler CH, Caviness JN, et al: A kindred with Parkinson's disease not showing genetic linkage to established loci. Neurology 54: 504-507, 2000
67. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al: Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367, 2009
68. Visscher PM: Sizing up human height variation. Nat Genet 40: 489-490, 2008
69. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al: Finding the missing heritability of complex diseases. Nature 461: 747-753, 2009
70. Sidransky E, Nails MA, Aasly JO, Aharon-Peretz J, Annesi G, et al: Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361: 1651-1661, 2009
71. Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, et al: Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66: 571576, 2009
72. Brain Nerve 63: 491-496, 2011